Does the Microflora of Surgery Site Infection Change After Prophylactic Use of Vancomycin Powder in the Spine Surgery
Weiran Hu,Hongqiang Wang,Xiaonan Wu,Xinge Shi,Haohao Ma,Kai Zhang,Yanzheng Gao
DOI: https://doi.org/10.2147/IDR.S390837
2023-01-06
Infection and Drug Resistance
Abstract:Weiran Hu, 1, 2, &ast Hongqiang Wang, 1, 2, &ast Xiaonan Wu, 1, 3 Xinge Shi, 1, 2 Haohao Ma, 1, 2 Kai Zhang, 1, 2 Yanzheng Gao 1, 2 1 Department of Spine and Spinal Cord Surgery, Henan Provincial People's Hospital, Zhengzhou, People's Republic of China; 2 Department of Spine and Spinal Cord Surgery, People's Hospital of Zhengzhou University, Zhengzhou, People's Republic of China; 3 Department of Spine and Spinal Cord Surgery, People's Hospital of Henan University, Zhengzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yanzheng Gao, Department of Spine and Spinal Cord Surgery, Henan Provincial People's Hospital, No. 7, Wei Wu Road, Zhengzhou, 450003, People's Republic of China, Email Study Design: Retrospective cohort study. Objective: This study aimed to investigate the characteristics of microflora in patients with deep spinal surgical site infection (SSI) after prophylactic use of vancomycin powder (VP). Methods: A retrospective analysis was performed on patients after spinal surgery. Patients were grouped according to whether VP use and only patients with deep SSI were included in this study. General information of the patients, the dose of vancomycin, bacterial culture results, drug sensitivity test results, and SSI treatment methods were recorded. The differences of microflora between the two groups were analyzed, and the sensitivity of bacteria in the +VP group to antibiotics was analyzed. Results: The infection rate in the +VP group was 4.9% (56/1124) vs 6.3% (93/1476) in the No-VP group (P < 0.05). The proportion of Gram-positive bacteria (GPB) in the +VP SSIs was 55.4% vs.74.1% in the No-VP group (P < 0.05). The percentage of Gram-negative bacteria (GNB) in the +VP SSIs was 46.4% vs.30.1% in the No-VP group (P 1g SSIs was higher (59.0% vs 32.4%, P < 0.05). In the +VP SSIs, all of the GNB cultured were sensitive to meropenem, and linezolid covered most of the GPB cultured. Conclusion: Local use of vancomycin powder can reduce the incidence of SSI, but this may lead to changes in the bacterial flora. Once the SSI occurs, the case of GNB infection may be increased. The more dose of VP cannot decrease SSI but may increase the rate of GNB in the +VP SSIs. Once infections still occur after VP use, antibiotics covering GNB may be added. These findings may help guide choice of empiric antibiotics while awaiting culture data. Keywords: surgery site infection, microflora, spine, vancomycin Surgical site infection (SSI) is a serious complication of spinal surgery, which can lead to failure of internal fixation, spinal instability, neurological dysfunction, sepsis, death, and increased medical costs. 1–3 Vancomycin is a glycopeptide antibiotic that acts mainly by destroying the cell walls of sensitive bacteria. Topical use of vancomycin powder in spinal surgery not only creates a higher drug concentration at the surgical site but also reduces drug diffusion in blood, so it has the dual advantages of improving antimicrobial efficiency and reducing the side effects. 3 Many studies have shown that prophylactic use of vancomycin powder can effectively reduce the incidence of SSI. 1,4–7 However, SSI still occurs after prophylactic use of vancomycin. Many studies reported that the SSI rate after VP use is 0.9–3.1%, which shows that VP dose did not completely eliminate SSI. 4,5,7 Previous studies have shown that GPB are the main pathogenic bacteria, followed by GNB and anaerobes in SSIs, 8 but all the studies of microflora were based on patients without VP use. Whether vancomycin alters the microflora of SSIs remains unknown. Antibiotics are the mainstay treatment for deep site infections after spinal surgery. It is important to know the type of infection, and broad-spectrum antibiotics should be administered as soon as possible when SSI occurs. 9,10 Whether the use of vancomycin powder causes changes in bacterioflora is still unknown, this will affect the treatment strategy for the secondary infection. Therefore, we retrospectively analyzed SSIs after topical use of VP. The change of microflora and treatment strategy of the secondary infections were analyzed, aiming to help guide the choice of empiric antibiotics while awaiting culture data and improve the antimicrobial prophylaxis strategies for SSI after topical use of VP. A retrospective analysis was performed on patients who underwent spinal s -Abstract Truncated-